Animal Health Division Represents Growth for Biotech Distributor

May 7, 2011

Specialty biotech distributor announces twenty-five percent (25%) monthly growth rate of animal health division within rapidly expanding marketplace.

Columbia, SC (PRWEB) May 06, 2011

BDI Pharma, Inc., the nation’s fastest growing distributor of biotech therapies, announced continued growth in its expansion into the animal health market. 4legPharma, the Animal Health Division of BDI Pharma, was launched in October, 2010 to provide veterinarians and veterinary specialists a safe and reliable resource for those specialty biopharmaceuticals used to treat pets suffering from many of the same chronic, life-threatening conditions affecting humans.

Building on a successful launch last fall, the company’s recorded sales revenue and units sold for this unique market segment is trending well over 25% in monthly growth year to date. The veterinary customer base has grown by 127% and, though less than six months old, the division’s website, http://www.4legpharma.com, attracts a daily average of over 2,000 hits.

“It appears that both our instincts and analysis were correct and the commitment of BDI resources in an effort to cater to the needs of the specialty veterinary marketplace has been well received,” stated Angela Phillips, Director of 4legPharma. “The response of the veterinary community has been extremely positive. We are now an active member of the AVDA, and have developed long-term business partnerships with several industry-leading companies that will bring innovative, cost-effective solutions to those caring for our companion animals.”

About BDI Pharma, Inc.

Since 1995, BDI Pharma has defined its customer-centric approach to serving the nation’s healthcare community through innovative supply solutions, unparalleled customer service, extensive product knowledge, 24/7 emergency availability and urgent-need delivery. An open-access resource for reference material, educational literature, market data and online ordering, bdipharma.com (ivig.com) has become an industry-renowned point of reference. Proprietary programs for specialty veterinarians — 4legpharma.com; product consignment — consignadvantage.com; flu vaccine pre-booking and general vaccine ordering — securivax.com; and purchasing/reward programs — qoreprogram.com and securigam.com round out a family of solutions tailored to the needs of the healthcare community at large.

BDI Pharma’s portfolio includes branded and generic specialty pharmaceuticals, chemotherapy products, vaccines, albumin, IVIG, coagulation factors, high-titer or “hyper” immune globulins, and other specialty injectables. BDI Pharma is recognized as an “ADR,” or Authorized Distributor of Record, for all of the manufacturers it represents.

# # #

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2011/5/prweb8394080.htm

Source: prweb

comments powered by Disqus